Jessica Ortiz is a highly accomplished lawyer who draws on her extensive experience as an Assistant United States Attorney in the United States Attorney’s Office for the Southern District of New York, where she served for over eight years, ending her tenure as Chief of the Narcotics Unit.
Ms. Ortiz represents companies and individuals in high-stakes civil litigation and white collar criminal and regulatory investigations and enforcement actions brought by the Department of Justice, the Securities and Exchange Commission, and other federal and state regulators. She is also called upon to conduct corporate internal investigations in the U.S. and abroad and to advise clients on crisis and risk management.
At the U.S. Attorney’s Office, Ms. Ortiz supervised investigations and prosecutions of domestic and international money laundering, narcotics conspiracies and distribution, health care fraud and misconduct by physicians and medical practitioners involving prescription drugs and violent crimes. Prior to her supervisory appointment, Ms. Ortiz investigated and prosecuted a wide range of federal crimes including bank, mail, and wire fraud, computer crimes and misuse, corporate theft, public corruption, racketeering and organized crime, as well as murder, assault, narcotics trafficking, stalking, threats, robbery, and kidnapping.
In her courtroom work at the U.S. Attorney’s Office, Ms. Ortiz led 15 jury trials to conviction as lead counsel, including a 3-month RICO enterprise trial stemming from a 76-defendant prosecution. In addition to her successful trial work, Ms. Ortiz has extensive appellate experience, having briefed eight and argued three appeals before the United States Court of Appeals for the Second Circuit.
Ms. Ortiz previously practiced securities litigation at Weil, Gotshal & Manges, LLP. Prior to law school, Ms. Ortiz was a Senior Technology Security Associate for the Global Risk Management Service of PricewaterhouseCoopers LLP.
When the federal government passes a large stimulus package, investigations and litigation under the False Claims Act quickly follow. The CARES Act passed in response to the COVID-19 crisis promises to be no different. The bill even creates an inspec...